Article
Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?
2018-05-25
Abstract excerpt
Recent changes in lung cancer care, including new approvals in first line and the introduction of high throughput molecular technologies in routine testing led us to question ourselves on how deeper molecular testing may be helpful for the optimal use of targeted drugs. In this article we review recent results in the scope of personalized medicine in lung cancer. We discuss biomarkers that have a therapeutic predi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0eb41a07-4460-5f32-9dd1-d9f79e3a1d31
- DOI
- 10.20944/preprints201805.0357.v1
